ATLAS fair value
ATLAS has no fair value for this stock today.
Peptron stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology & Medical Research · KOSDAQ · South Korea
Prices as of Oct 26, 2026 · KRW
ATLAS has no fair value for this stock today.
43%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Peptron a 43% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between ₩75,673 and ₩114,519; in 9 out of 10, between ₩52,413 and ₩165,343. Estimated annual volatility is 126%.
ATLAS does not publish a fair value for 087010.KQ right now, but it does show its odds of rising: somewhat worse than a coin flip.
Over the last 52 weeks 087010.KQ has traded between ₩79,200 and ₩392,500. Today it is 75.0% below that high and 24% above its low.
Its beta is 0.74: it tends to move less than the market.
Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug.
Want to see everything about Peptron?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug.
43%: somewhat worse than a coin flip. In half of the simulated outcomes, 087010.KQ ends the month between ₩75,673 and ₩114,519.
Peptron's market capitalization is ₩2.1T. We do not show a P/E because it has no positive earnings to base one on.
ATLAS estimates annual volatility at 126%. In a typical month, half of the outcomes end between ₩75,673 and ₩114,519.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy